SignalX

Kolmar Korea FY 2025 Annual Report
Beta

Filed: March 18, 2026· period ending December 31, 2025DART
Kolmar Korea Overview

Kolmar Korea annual report for FY 2025, filed with DART (Korea Financial Supervisory Service) on March 18, 2026. This page provides AI-powered English analysis including business overview, management discussion & analysis (MD&A), risk factors, and KIFRS consolidated financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE).

Kolmar Korea FY 2025 Annual Report Analysis

Business Overview

  • • KRW 2.72T total revenue in FY2025, with 40.62% from basic cosmetics, 36.20% from prescription drugs (notably K-CAB)
  • • Portfolio expansion with Kolmar UX Co. included as consolidated subsidiary in FY2025, FY2024 new subsidiary M.O.D Materials sales KRW 15.5B

Risk Factors

  • • Foreign exchange risk managed by matching local currency transactions; speculative forex trades prohibited, no specific KRW sensitivity disclosed
  • • Currency swap derivative liabilities increased to KRW 1.80B from KRW 699M pre-tax loss at fiscal year-end 2025

Kolmar Korea FY 2025 Key Financial Metrics
DART

Total Assets

KRW 3.46T

▲ +10.6% YoY

Operating Cash Flow

KRW 291.4B

▲ +35.3% YoY

CapEx

KRW 164.0B

▼ -33.7% YoY

Source: KIFRS consolidated financial data from Kolmar Korea annual report on DART. All figures in KRW.

Source: DART (Korea Financial Supervisory Service) · AI summaries generated from the original Korean filing (English output) · Beta: coverage is expanding